Oral Testosterone Therapy
Showing 1 - 25 of >10,000
Drug Metabolism and Transport
Active, not recruiting
- Transgender Persons
- Midazolam oral solution
- +2 more
-
Seattle, WashingtonUniversity of Washington
Dec 21, 2022
Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore
Recruiting
- Prostate Cancer
- +2 more
- Testosterone Undecanoate
- Enzalutamide
-
Baltimore, MarylandJohns Hopkins Hospital
May 6, 2022
Hypogonadism, Male, Kidney Disease, Chronic Trial in Saint Louis (Jatenzo Pill)
Recruiting
- Hypogonadism, Male
- Kidney Disease, Chronic
- Jatenzo Pill
-
Saint Louis, MissouriSaint Louis Univeristy
Mar 15, 2022
Hypoactive Sexual Desire Disorder Trial in San Diego (Oral Testosterone Undecanoate)
Not yet recruiting
- Hypoactive Sexual Desire Disorder
- Oral Testosterone Undecanoate
-
San Diego, CaliforniaSan Diego Sexual Medicine
Oct 12, 2023
Arthroplasty, Replacement, Hip Trial in Des Plaines (Testosterone Therapy, No Testosterone Therapy)
Withdrawn
- Arthroplasty, Replacement, Hip
- Testosterone Therapy
- No Testosterone Therapy
-
Des Plaines, IllinoisAmerican Hip Institute Research Foundation
Feb 1, 2023
PCOS, Vitamin D Trial in Dhaka (Vitamin D3, Placebo Oral Tablet)
Recruiting
- PCOS
- Vitamin D
- Vitamin D3
- Placebo Oral Tablet
-
Dhaka, BangladeshBSMMU
Oct 29, 2023
Hypogonadism, Malignant Urinary System Tumor, Urinary System Disorder Trial in Atlanta (other, procedure, drug)
Recruiting
- Hypogonadism
- +3 more
- Best Practice
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jan 3, 2023
Boys With Pubertal Delay or Confirmed Hypogonadism
Recruiting
- Delayed Puberty
- Male Hypogonadism
- Testosterone Undecanoate
-
Buenos Aires, Distrito Federal, ArgentinaRodolfo Rey
Sep 12, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Laboratory Biomarker Analysis
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 19, 2022
Bariatric Surgery Candidate, Male Hypogonadism, Muscle Loss Trial in Esbjerg (Testosterone Undecanoate)
Recruiting
- Bariatric Surgery Candidate
- +2 more
- Testosterone Undecanoate
-
Esbjerg, DenmarkHospitalSWD
Oct 24, 2022
Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)
Not yet recruiting
- Prostate Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Prostate Cancer Trial in Brazil (Testosterone Cypionate, Darolutamide)
Recruiting
- Prostate Cancer
- Testosterone Cypionate
- Darolutamide
-
Brasília, Distrito Federal, Brazil
- +4 more
Dec 22, 2022
Sarcopenic Male Colorectal Cancer Patients
Recruiting
- Colorectal Cancer
- +4 more
-
London, United KingdomLondon North West University Healthcare NHS Trust
May 4, 2022
Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Testosterone Cypionate
- Sipuleucel-T
-
New Haven, ConnecticutYale Cancer Center
Oct 20, 2023
Prostate Cancer, Castration-Resistant Prostate Cancer Trial in Aurora (Transdermal Testosterone, Standard of Care, Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Castration-Resistant Prostate Cancer
- Transdermal Testosterone
- Standard of Care, Enzalutamide
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 31, 2022
Type 2 Diabetes, Hypogonadism Trial in Houston (Testosterone gel 1.62%, Placebo)
Recruiting
- Type 2 Diabetes Mellitus
- Hypogonadism
- Testosterone gel 1.62%
- Placebo
-
Houston, TexasMichael E. DeBakey VA Medical Center, Houston, TX
Dec 8, 2021
Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML
Recruiting
- Castration-resistant Prostate Cancer
- Homologous Recombination Deficiency
- Testosterone Enanthate 100 MG/ML Injectable Solution
- Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
-
Sydney, New South Wales, AustraliaKinghorn Cancer Centre, St. Vincent's Hospital
Dec 16, 2022
China Gender-affirming Hormone Therapy Study
Recruiting
- Transgender
- Gender Incongruence
- GAHT for transgender men
- GAHT for transgender women
-
Peking, Beijing, ChinaPeking University Third Hospital
Sep 27, 2022
Hypogonadism Trial in Birmingham, Los Angeles, San Antonio (Oral testosterone undecanoate (TU) (300 mg T equivalents/dose), Oral
Completed
- Hypogonadism
- Oral testosterone undecanoate (TU) (300 mg T equivalents/dose)
- +3 more
-
Birmingham, Alabama
- +3 more
Jun 23, 2021
Gram-negative Bacteremia Trial (Intravenous Antibiotics, Oral Antibiotics)
Not yet recruiting
- Gram-negative Bacteremia
- Intravenous Antibiotics
- Oral Antibiotics
- (no location specified)
Oct 6, 2023
Acute Gastroenteritis Trial (Fortified Oral Rehydration Therapy, Standard of Care Oral Rehydration Therapy)
Not yet recruiting
- Acute Gastroenteritis
- Fortified Oral Rehydration Therapy
- Standard of Care Oral Rehydration Therapy
- (no location specified)
Nov 16, 2023
Oral Lichen Planus Trial in Alexandria (Oral zinc supplement, triamcinolone acetonide Oral paste)
Completed
- Oral Lichen Planus
- Oral zinc supplement
- triamcinolone acetonide Oral paste
-
Alexandria, EgyptAlexandria Faculty of Dentistry
Sep 12, 2023
Muscle, Fat and Tissue Receptors
Active, not recruiting
- Gender Incongruence
- Transgenderism
- testosterone cypionate
- Estradiol Valerate
-
Saint Louis, MissouriSaint Louis Univeristy
Jan 13, 2023
Oral Lichen Planus Trial in Beijing (total glucosides of paeony treatment, photodynamic therapy treatment, glucosides of paeony
Recruiting
- Oral Lichen Planus
- total glucosides of paeony treatment
- +2 more
-
Beijing, ChinaPeking University Third Hospital
Jul 25, 2023